Quassinoids from the Root of Eurycoma longifolia and Their Antiproliferative Activity on Human Cancer Cell Lines
Nguyen Huu Tung2,3, Takuhiro Uto2, Nguyen Thanh Hai3, Gang Li2, Yukihiro Shoyama2★★ Corresponding author
- 1Department of Pharmacognosy, Faculty of Pharmaceutical Sciences, Nagasaki International University, Sasebo, Nagasaki 859-3298, Japan.
- 2Department of Pharmacy, School of Medicine and Pharmacy, Vietnam National University, Hanoi, Vietnam.
CORRESPONDENCE
Yukihiro Shoyama
Department of Pharmacy, School of Medicine and Pharmacy, Vietnam National University, Hanoi, Vietnam.
Received: 29-07-2016; Revised: 08-09-2016.
Volume 13, Issue 51 · pp. 459–462 · PUBLISHED 19 July 2017 · DOI: 10.4103/pm.pm_353_16
View on Pharmacogn. Mag. original site ↗
ABSTRACT
Background: The roots of Eurycoma longifolia Jack have traditionally been used as an aphrodisiac tonic besides the other remedies for boils, fever, bleeding gums, and wound ulcer. Recently, the antiproliferative activity of E. longifolia has been reported and remained attractive to natural chemists. Objective: The objective of this study was to study on antiproliferative compounds from the root of E. longifolia. Materials and Methods: Column chromatography was used to separate individual compounds, spectroscopic data including nuclear magnetic resonances and mass spectrometry were analyzed to determine the chemical structure of the isolates and for biological testing, antiproliferative activity of compounds was tested on seven human cancer cell lines (KATO III, HCT-15, Colo205, HepG2, PC-3, Jurkat, HL-60) by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide method. Results: Nine quassinoids including a new C19 longilactone-type quassinoid glycoside were characterized from the roots of the title plant. Among them, the major quassinoid eurycomanone exhibited selectively potential antiproliferative activities on the leukemia cell lines (HL-60 and Jurkat) and had very low toxic effects on normal skin fibroblast cell line (NB1RGB). Conclusion: The current study reveals one new quassinoid glycoside and the potential active component (eurycomanone) from E. longifolia for the leukemia treatment.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Tung, N. H., Uto, T., Hai, N. T., Li, G., & Shoyama, Y. (2017). Quassinoids from the Root of Eurycoma longifolia and Their Antiproliferative Activity on Human Cancer Cell Lines. Pharmacognosy Magazine, 13(51), 459–462. https://doi.org/10.4103/pm.pm_353_16